Allurion Technologies, Inc. Proceeds from Issuance of Private Placement
Allurion Technologies, Inc. (ALUR) reported Proceeds from Issuance of Private Placement of $4.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2026-03-30
- Allurion Technologies, Inc. proceeds from issuance of private placement for the quarter ending 2024-12-31 was -$93.00K.
- Allurion Technologies, Inc. proceeds from issuance of private placement for fiscal 2025 was $4.60M, a 77.35% increase from fiscal 2024.
- Allurion Technologies, Inc. proceeds from issuance of private placement for fiscal 2024 was $2.59M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|
| 2025-12-31 | $4.60M 10-K · filed 2026-03-30 | ||
| 2024-12-31 | -$93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $2.59M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $2.69M 10-Q · filed 2025-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |